_id

6919e2543c536f8df2317f98

Ticker

0RGI.LSE

Name

COSMO Pharmaceuticals SA

Exchange

LSE

Address

Riverside II, Dublin, Ireland, 2

Country

UK

Sector

Industry

Currency

GBP

Website

https://www.cosmopharma.com

Description

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with a faster and less risky excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Relafalk, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers' diarrhoea; and Byfavo, an intravenous benzodiazepine sedative/anesthetic. It is also developing Breezula, a novel androgen receptor inhibitor, which is in Phase III trials and targets androgen receptors in the scalp; Rifamycin 1% enema that is in Phase II clinical trial for the treatment of distal ulcerative colitis and proctitis; Colesevelam, which is in preclinical studies for the treatment of bile acid diarrhea; and Cortexolone 17a-valerate-21-propionate, an oral Androgen receptor and glucocorticoid receptor antagonist that is in Phase I clinical trial for treatment solid tumors, as well as provides Cosmo's AI technology, a GI Genius intelligent endoscopy system. The company has development, distribution, and licensing agreements with Bausch Health, Ferring, China Medical System Holdings Limited, Medtronic, RedHill Biopharma Ltd., Sun Pharmaceutical Industries Ltd., 3SBio, InfectoPharm, and Hyphens Pharma International Limited. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland.

Last Close

99.41417758089

Volume

1346

Current Price

107.8

Change

-0.3251608460241845

Last Updated

2025-12-29T14:47:43.416Z

Image

https://logo.clearbit.com/www.cosmopharma.com

Ipo Date

-

Market Cap

1542983424

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-06-30

Revenue

51720000

Cost Of Revenue

25571000

Gross Profit

26149000

Operating Expenses

27560000

Operating Income

-1411000

Interest Expense

-

Pretax Income

-670000

Net Income

-2005999

Eps

-0.12560620206917222

Dividends Per Share

24512000

Shares Outstanding

15002100

Income Tax Expense

1360000

EBITDA

4852000

Operating Margin

-2.72815158546017

Total Other Income Expense Net

741000

Cash

50749000

Short Term Investments

1182000

Receivables

21616000

Inventories

12379000

Total Current Assets

187226000

Property Plant Equipment

29774000

Total Assets

610330000

Payables

11027000

Short Term Debt

756000

Long Term Debt

-

Total Liabilities

143354000

Equity

460239000

Bs_currency_symbol

-

Depreciation

6263000

Change In Working Capital

-5339000

Cash From Operations

900000

Capital Expenditures

2624000

Cash From Investing

41974000

Cash From Financing

-34203000

Net Change In Cash

50749000

Cf_currency_symbol

-

PE

0.8026

PB

3.740718017812484

ROE

-0.4358602812886348

ROA

-0.32867448757229695

FCF

-1724000

Fcf Percent

-0.03333333333333333

Piotroski FScore

2

Health Score

31

Deep Value Investing Score

6

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

2.5

Growth Investing Score

1.5

Momentum Investing Score

7.5

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

6.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

51720000

Quarters > 0 > income Statement > cost Of Revenue

25571000

Quarters > 0 > income Statement > gross Profit

26149000

Quarters > 0 > income Statement > operating Expenses

27560000

Quarters > 0 > income Statement > operating Income

-1411000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-670000

Quarters > 0 > income Statement > net Income

-2005999

Quarters > 0 > income Statement > eps

-0.12560620206917222

Quarters > 0 > income Statement > dividends Per Share

24512000

Quarters > 0 > income Statement > shares Outstanding

15970541

Quarters > 0 > income Statement > income Tax Expense

1360000

Quarters > 0 > income Statement > EBITDA

4852000

Quarters > 0 > income Statement > operating Margin

-2.72815158546017

Quarters > 0 > income Statement > total Other Income Expense Net

741000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

50749000

Quarters > 0 > balance Sheet > short Term Investments

1182000

Quarters > 0 > balance Sheet > receivables

21616000

Quarters > 0 > balance Sheet > inventories

12379000

Quarters > 0 > balance Sheet > total Current Assets

187226000

Quarters > 0 > balance Sheet > property Plant Equipment

29774000

Quarters > 0 > balance Sheet > total Assets

610330000

Quarters > 0 > balance Sheet > payables

11027000

Quarters > 0 > balance Sheet > short Term Debt

756000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

143354000

Quarters > 0 > balance Sheet > equity

460239000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

-2005999

Quarters > 0 > cash Flow > depreciation

6263000

Quarters > 0 > cash Flow > change In Working Capital

-5339000

Quarters > 0 > cash Flow > cash From Operations

900000

Quarters > 0 > cash Flow > capital Expenditures

2624000

Quarters > 0 > cash Flow > cash From Investing

41974000

Quarters > 0 > cash Flow > cash From Financing

-34203000

Quarters > 0 > cash Flow > net Change In Cash

50749000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.12560620206917222

Quarters > 0 > ratios > PB

3.740718017812484

Quarters > 0 > ratios > ROE

-0.4358602812886348

Quarters > 0 > ratios > ROA

-0.32867448757229695

Quarters > 0 > ratios > FCF

-1724000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.03333333333333333

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2024-12-31

Quarters > 1 > income Statement > revenue

130551000

Quarters > 1 > income Statement > cost Of Revenue

-3285000

Quarters > 1 > income Statement > gross Profit

133836000

Quarters > 1 > income Statement > operating Expenses

71908000

Quarters > 1 > income Statement > operating Income

61928000

Quarters > 1 > income Statement > interest Expense

53000

Quarters > 1 > income Statement > pretax Income

64619000

Quarters > 1 > income Statement > net Income

57245000

Quarters > 1 > income Statement > eps

3.4867669140325117

Quarters > 1 > income Statement > dividends Per Share

32094000

Quarters > 1 > income Statement > shares Outstanding

16417788

Quarters > 1 > income Statement > income Tax Expense

7486000

Quarters > 1 > income Statement > EBITDA

71459000

Quarters > 1 > income Statement > operating Margin

47.435867974967636

Quarters > 1 > income Statement > total Other Income Expense Net

2691000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

44296000

Quarters > 1 > balance Sheet > short Term Investments

98667000

Quarters > 1 > balance Sheet > receivables

18941000

Quarters > 1 > balance Sheet > inventories

13510000

Quarters > 1 > balance Sheet > total Current Assets

202258000

Quarters > 1 > balance Sheet > property Plant Equipment

29088000

Quarters > 1 > balance Sheet > total Assets

646772000

Quarters > 1 > balance Sheet > payables

9100000

Quarters > 1 > balance Sheet > short Term Debt

817000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

141681000

Quarters > 1 > balance Sheet > equity

498330000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

77376000

Quarters > 1 > cash Flow > depreciation

4993000

Quarters > 1 > cash Flow > change In Working Capital

-2625000

Quarters > 1 > cash Flow > cash From Operations

63225000

Quarters > 1 > cash Flow > capital Expenditures

4225000

Quarters > 1 > cash Flow > cash From Investing

-39383000

Quarters > 1 > cash Flow > cash From Financing

-34856000

Quarters > 1 > cash Flow > net Change In Cash

42155500

Quarters > 1 > cash Flow > currency_symbol

-

Quarters > 1 > ratios > PE

3.4867669140325117

Quarters > 1 > ratios > PB

3.5515372271386427

Quarters > 1 > ratios > ROE

11.487367808480323

Quarters > 1 > ratios > ROA

8.850877898239256

Quarters > 1 > ratios > FCF

59000000

Quarters > 1 > ratios > Piotroski FScore

4

Quarters > 1 > ratios > fcf Percent

0.4519306631125001

Quarters > 1 > health Score

82

Quarters > 2 > quarter

2024-06-30

Quarters > 2 > income Statement > revenue

136237000

Quarters > 2 > income Statement > cost Of Revenue

23150000

Quarters > 2 > income Statement > gross Profit

113087000

Quarters > 2 > income Statement > operating Expenses

26133000

Quarters > 2 > income Statement > operating Income

86954000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

88748000

Quarters > 2 > income Statement > net Income

75991000

Quarters > 2 > income Statement > eps

4.70525340604719

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

16150246

Quarters > 2 > income Statement > income Tax Expense

12690000

Quarters > 2 > income Statement > EBITDA

94246000

Quarters > 2 > income Statement > operating Margin

63.825539317512856

Quarters > 2 > income Statement > total Other Income Expense Net

1794000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

54556000

Quarters > 2 > balance Sheet > short Term Investments

78858000

Quarters > 2 > balance Sheet > receivables

23649000

Quarters > 2 > balance Sheet > inventories

13902000

Quarters > 2 > balance Sheet > total Current Assets

183594000

Quarters > 2 > balance Sheet > property Plant Equipment

27372000

Quarters > 2 > balance Sheet > total Assets

638252000

Quarters > 2 > balance Sheet > payables

14675000

Quarters > 2 > balance Sheet > short Term Debt

741000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

132866000

Quarters > 2 > balance Sheet > equity

498443000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

75991000

Quarters > 2 > cash Flow > depreciation

7292000

Quarters > 2 > cash Flow > change In Working Capital

2738000

Quarters > 2 > cash Flow > cash From Operations

99186000

Quarters > 2 > cash Flow > capital Expenditures

1428000

Quarters > 2 > cash Flow > cash From Investing

-80120000

Quarters > 2 > cash Flow > cash From Financing

-5368000

Quarters > 2 > cash Flow > net Change In Cash

2140500

Quarters > 2 > cash Flow > currency_symbol

-

Quarters > 2 > ratios > PE

4.70525340604719

Quarters > 2 > ratios > PB

3.4928698342638977

Quarters > 2 > ratios > ROE

15.245675032049801

Quarters > 2 > ratios > ROA

11.906112319272012

Quarters > 2 > ratios > FCF

97758000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.7175583725419673

Quarters > 2 > health Score

86

Quarters > 3 > quarter

2024-03-31

Quarters > 3 > income Statement > revenue

68118500

Quarters > 3 > income Statement > cost Of Revenue

11575000

Quarters > 3 > income Statement > gross Profit

56543500

Quarters > 3 > income Statement > operating Expenses

12640999

Quarters > 3 > income Statement > operating Income

43477000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

44374000

Quarters > 3 > income Statement > net Income

37995500

Quarters > 3 > income Statement > eps

2.352626703023595

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

16150246

Quarters > 3 > income Statement > income Tax Expense

6345000

Quarters > 3 > income Statement > EBITDA

47123000

Quarters > 3 > income Statement > operating Margin

63.825539317512856

Quarters > 3 > income Statement > total Other Income Expense Net

897000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

54556000

Quarters > 3 > balance Sheet > short Term Investments

19418000

Quarters > 3 > balance Sheet > receivables

23649000

Quarters > 3 > balance Sheet > inventories

13902000

Quarters > 3 > balance Sheet > total Current Assets

183594000

Quarters > 3 > balance Sheet > property Plant Equipment

27372000

Quarters > 3 > balance Sheet > total Assets

638252000

Quarters > 3 > balance Sheet > payables

14675000

Quarters > 3 > balance Sheet > short Term Debt

741000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

132866000

Quarters > 3 > balance Sheet > equity

498443000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

37995500

Quarters > 3 > cash Flow > depreciation

3646000

Quarters > 3 > cash Flow > change In Working Capital

1369000

Quarters > 3 > cash Flow > cash From Operations

49593000

Quarters > 3 > cash Flow > capital Expenditures

714000

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-2684000

Quarters > 3 > cash Flow > net Change In Cash

2140500

Quarters > 3 > cash Flow > currency_symbol

-

Quarters > 3 > ratios > PE

2.352626703023595

Quarters > 3 > ratios > PB

3.4928698342638977

Quarters > 3 > ratios > ROE

7.622837516024901

Quarters > 3 > ratios > ROA

5.953056159636006

Quarters > 3 > ratios > FCF

48879000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.7175583725419673

Quarters > 3 > health Score

76

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

266788000

Annuals > 0 > income Statement > cost Of Revenue

19865000

Annuals > 0 > income Statement > gross Profit

246923000

Annuals > 0 > income Statement > operating Expenses

98041000

Annuals > 0 > income Statement > operating Income

148882000

Annuals > 0 > income Statement > interest Expense

114313

Annuals > 0 > income Statement > pretax Income

153367000

Annuals > 0 > income Statement > net Income

133236000

Annuals > 0 > income Statement > eps

8.115344162075914

Annuals > 0 > income Statement > dividends Per Share

32094000

Annuals > 0 > income Statement > shares Outstanding

16417788

Annuals > 0 > income Statement > income Tax Expense

20176000

Annuals > 0 > income Statement > EBITDA

165705000

Annuals > 0 > income Statement > operating Margin

55.805358561854355

Annuals > 0 > income Statement > total Other Income Expense Net

4485000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

44296000

Annuals > 0 > balance Sheet > short Term Investments

98667000

Annuals > 0 > balance Sheet > receivables

18941000

Annuals > 0 > balance Sheet > inventories

13510000

Annuals > 0 > balance Sheet > total Current Assets

202258000

Annuals > 0 > balance Sheet > property Plant Equipment

29088000

Annuals > 0 > balance Sheet > total Assets

646772000

Annuals > 0 > balance Sheet > payables

9100000

Annuals > 0 > balance Sheet > short Term Debt

817000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

141681000

Annuals > 0 > balance Sheet > equity

498330000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

153367000

Annuals > 0 > cash Flow > depreciation

12285000

Annuals > 0 > cash Flow > change In Working Capital

113000

Annuals > 0 > cash Flow > cash From Operations

162411000

Annuals > 0 > cash Flow > capital Expenditures

5653000

Annuals > 0 > cash Flow > cash From Investing

-128881000

Annuals > 0 > cash Flow > cash From Financing

-40224000

Annuals > 0 > cash Flow > net Change In Cash

-5979000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

8.115344162075914

Annuals > 0 > ratios > PB

3.485645998434772

Annuals > 0 > ratios > ROE

26.73649990969839

Annuals > 0 > ratios > ROA

20.600149666343007

Annuals > 0 > ratios > FCF

156758000

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

0.5875751533052461

Annuals > 0 > health Score

89

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

92780000

Annuals > 1 > income Statement > cost Of Revenue

39340000

Annuals > 1 > income Statement > gross Profit

53440000

Annuals > 1 > income Statement > operating Expenses

47294000

Annuals > 1 > income Statement > operating Income

6146000

Annuals > 1 > income Statement > interest Expense

8526000

Annuals > 1 > income Statement > pretax Income

1532000

Annuals > 1 > income Statement > net Income

-4932000

Annuals > 1 > income Statement > eps

-0.3062379211586374

Annuals > 1 > income Statement > dividends Per Share

16890000

Annuals > 1 > income Statement > shares Outstanding

16105125

Annuals > 1 > income Statement > income Tax Expense

6264000

Annuals > 1 > income Statement > EBITDA

19699000

Annuals > 1 > income Statement > operating Margin

6.624272472515629

Annuals > 1 > income Statement > total Other Income Expense Net

-4614000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

50275000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

28454000

Annuals > 1 > balance Sheet > inventories

14198000

Annuals > 1 > balance Sheet > total Current Assets

102226000

Annuals > 1 > balance Sheet > property Plant Equipment

28588000

Annuals > 1 > balance Sheet > total Assets

553980000

Annuals > 1 > balance Sheet > payables

8783000

Annuals > 1 > balance Sheet > short Term Debt

897000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

124944000

Annuals > 1 > balance Sheet > equity

422160000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

1532000

Annuals > 1 > cash Flow > depreciation

14261000

Annuals > 1 > cash Flow > change In Working Capital

946000

Annuals > 1 > cash Flow > cash From Operations

22708000

Annuals > 1 > cash Flow > capital Expenditures

4396000

Annuals > 1 > cash Flow > cash From Investing

42303000

Annuals > 1 > cash Flow > cash From Financing

-211266000

Annuals > 1 > cash Flow > net Change In Cash

-135550000

Annuals > 1 > cash Flow > currency_symbol

EUR

Annuals > 1 > ratios > PE

-0.3062379211586374

Annuals > 1 > ratios > PB

4.036200078169414

Annuals > 1 > ratios > ROE

-1.168277430358158

Annuals > 1 > ratios > ROA

-0.8902848478284415

Annuals > 1 > ratios > FCF

18312000

Annuals > 1 > ratios > Piotroski FScore

2

Annuals > 1 > ratios > fcf Percent

0.19737012287130848

Annuals > 1 > health Score

48

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

102089000

Annuals > 2 > income Statement > cost Of Revenue

18762000

Annuals > 2 > income Statement > gross Profit

83327000

Annuals > 2 > income Statement > operating Expenses

55270000

Annuals > 2 > income Statement > operating Income

28057000

Annuals > 2 > income Statement > interest Expense

9306759

Annuals > 2 > income Statement > pretax Income

24473000

Annuals > 2 > income Statement > net Income

17225000

Annuals > 2 > income Statement > eps

1.0486810210652469

Annuals > 2 > income Statement > dividends Per Share

15451414

Annuals > 2 > income Statement > shares Outstanding

16425395

Annuals > 2 > income Statement > income Tax Expense

6968000

Annuals > 2 > income Statement > EBITDA

46744000

Annuals > 2 > income Statement > operating Margin

27.482882582844383

Annuals > 2 > income Statement > total Other Income Expense Net

-3584000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

185825000

Annuals > 2 > balance Sheet > short Term Investments

55128000

Annuals > 2 > balance Sheet > receivables

38612000

Annuals > 2 > balance Sheet > inventories

11498000

Annuals > 2 > balance Sheet > total Current Assets

306097000

Annuals > 2 > balance Sheet > property Plant Equipment

30277000

Annuals > 2 > balance Sheet > total Assets

759592000

Annuals > 2 > balance Sheet > payables

7588000

Annuals > 2 > balance Sheet > short Term Debt

171827000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

295804000

Annuals > 2 > balance Sheet > equity

456927000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

17053284

Annuals > 2 > cash Flow > depreciation

13717870

Annuals > 2 > cash Flow > change In Working Capital

-12413999

Annuals > 2 > cash Flow > cash From Operations

32894771

Annuals > 2 > cash Flow > capital Expenditures

4470980

Annuals > 2 > cash Flow > cash From Investing

1689000

Annuals > 2 > cash Flow > cash From Financing

-45673102

Annuals > 2 > cash Flow > net Change In Cash

-22203541

Annuals > 2 > cash Flow > currency_symbol

GBP

Annuals > 2 > ratios > PE

1.0486810210652469

Annuals > 2 > ratios > PB

3.80324820157268

Annuals > 2 > ratios > ROE

3.7697487782512304

Annuals > 2 > ratios > ROA

2.2676647463375077

Annuals > 2 > ratios > FCF

28423791

Annuals > 2 > ratios > Piotroski FScore

4

Annuals > 2 > ratios > fcf Percent

0.278421681082193

Annuals > 2 > health Score

66

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

65074000

Annuals > 3 > income Statement > cost Of Revenue

15140000

Annuals > 3 > income Statement > gross Profit

49934000

Annuals > 3 > income Statement > operating Expenses

20996000

Annuals > 3 > income Statement > operating Income

11101000

Annuals > 3 > income Statement > interest Expense

8990000

Annuals > 3 > income Statement > pretax Income

24003000

Annuals > 3 > income Statement > net Income

21672000

Annuals > 3 > income Statement > eps

1.2820588663315204

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

16904060

Annuals > 3 > income Statement > income Tax Expense

2330000

Annuals > 3 > income Statement > EBITDA

17811000

Annuals > 3 > income Statement > operating Margin

17.05904047699542

Annuals > 3 > income Statement > total Other Income Expense Net

12902000

Annuals > 3 > income Statement > currency_symbol

GBP

Annuals > 3 > balance Sheet > cash

198560000

Annuals > 3 > balance Sheet > short Term Investments

23647000

Annuals > 3 > balance Sheet > receivables

24451000

Annuals > 3 > balance Sheet > inventories

13119000

Annuals > 3 > balance Sheet > total Current Assets

275849000

Annuals > 3 > balance Sheet > property Plant Equipment

30478000

Annuals > 3 > balance Sheet > total Assets

805562000

Annuals > 3 > balance Sheet > payables

4102000

Annuals > 3 > balance Sheet > short Term Debt

889000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

292884000

Annuals > 3 > balance Sheet > equity

505276000

Annuals > 3 > balance Sheet > currency_symbol

GBP

Annuals > 3 > cash Flow > net Income

24003000

Annuals > 3 > cash Flow > depreciation

7369000

Annuals > 3 > cash Flow > change In Working Capital

-5072000

Annuals > 3 > cash Flow > cash From Operations

12611000

Annuals > 3 > cash Flow > capital Expenditures

8504000

Annuals > 3 > cash Flow > cash From Investing

24857000

Annuals > 3 > cash Flow > cash From Financing

-27247000

Annuals > 3 > cash Flow > net Change In Cash

12623000

Annuals > 3 > cash Flow > currency_symbol

GBP

Annuals > 3 > ratios > PE

1.2820588663315204

Annuals > 3 > ratios > PB

3.539549766860092

Annuals > 3 > ratios > ROE

4.289140984333315

Annuals > 3 > ratios > ROA

2.6902957190135584

Annuals > 3 > ratios > FCF

4107000

Annuals > 3 > ratios > Piotroski FScore

3

Annuals > 3 > ratios > fcf Percent

0.06311276393029475

Annuals > 3 > health Score

52

Valuation > metrics > PE

0.8026

Valuation > metrics > PB

3.740718017812484

Valuation > final Score

62.59281982187516

Valuation > verdict

33.6% Undervalued

Profitability > metrics > ROE

-0.4358602812886348

Profitability > metrics > ROA

-1.0714318524136603

Profitability > metrics > Net Margin

-0.0387857501933488

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3114772976649089

Risk > metrics > Interest Coverage

-0.25552336110105034

Risk > final Score

59

Risk > verdict

High

Liquidity > metrics > Current Ratio

15.88950182466265

Liquidity > metrics > Quick Ratio

14.838920478655691

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

64.48462772861357

Prev Valuations > 1

65.07130165736102

Prev Valuations > 2

65.07130165736102

Prev Profitabilities > 0

83

Prev Profitabilities > 1

90

Prev Profitabilities > 2

75

Prev Risks > 0

100

Prev Risks > 1

100

Prev Risks > 2

100

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T22:58:49.721Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-09

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2025-06-30

Earnings History > 1 > report Date

2025-07-23

Earnings History > 1 > date

2025-06-30

Earnings History > 1 > before After Market

AfterMarket

Earnings History > 1 > currency

-

Earnings History > 1 > eps Actual

-0.13

Earnings History > 1 > eps Estimate

-

Earnings History > 1 > eps Difference

0

Earnings History > 1 > surprise Percent

-

Earnings History > 2 > period

2024-12-31

Earnings History > 2 > report Date

2025-03-21

Earnings History > 2 > date

2024-12-31

Earnings History > 2 > before After Market

-

Earnings History > 2 > currency

-

Earnings History > 2 > eps Actual

3.43

Earnings History > 2 > eps Estimate

0

Earnings History > 2 > eps Difference

3.43

Earnings History > 2 > surprise Percent

-